Integra Lifesciences Holdings (IART) Liabilities and Shareholders Equity (2009 - 2026)
Integra Lifesciences Holdings recorded quarterly Liabilities and Shareholders Equity of $3.6 billion in Q1 2026, down 0.67% quarter-over-quarter from $3.6 billion in Q4 2025, and down 11.72% year-over-year from $4.1 billion in Q1 2025.
Integra Lifesciences Holdings' Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $3.6 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 11.72% year-over-year to $3.6 billion; the TTM figure through Mar 2026 stood at $14.5 billion (down 10.7% YoY), while the FY2025 annual figure was $3.6 billion, down 10.78% from the prior year.
- Liabilities and Shareholders Equity came in at $3.6 billion for Q1 2026 at Integra Lifesciences Holdings, down from $3.6 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $4.1 billion in Q1 2024 to a low of $3.6 billion in Q1 2026.
- A 5-year average of $3.8 billion and a median of $3.8 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity advanced 8.97% in 2024 and declined 11.72% in 2026, its largest moves.
- Integra Lifesciences Holdings' Liabilities and Shareholders Equity stood at $3.9 billion in 2022, then fell by 2.77% to $3.8 billion in 2023, then grew by 6.75% to $4.0 billion in 2024, then slipped by 10.78% to $3.6 billion in 2025, then fell by 0.67% to $3.6 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $3.6 billion, $3.6 billion, and $3.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn | 3.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.58 Bn |
| Dec 31, 2025 | 3.60 Bn |
| Sep 30, 2025 | 3.65 Bn |
| Jun 30, 2025 | 3.67 Bn |
| Mar 31, 2025 | 4.05 Bn |
| Dec 31, 2024 | 4.04 Bn |
| Sep 30, 2024 | 4.07 Bn |
| Jun 30, 2024 | 4.07 Bn |
| Mar 31, 2024 | 4.08 Bn |
| Dec 31, 2023 | 3.78 Bn |
| Sep 30, 2023 | 3.74 Bn |
| Jun 30, 2023 | 3.78 Bn |
| Mar 31, 2023 | 3.74 Bn |
| Dec 31, 2022 | 3.89 Bn |
| Sep 30, 2022 | 3.81 Bn |
| Jun 30, 2022 | 3.75 Bn |
| Mar 31, 2022 | 3.67 Bn |
| Dec 31, 2021 | 3.78 Bn |
| Sep 30, 2021 | 3.77 Bn |
| Jun 30, 2021 | 3.71 Bn |
| Mar 31, 2021 | 3.74 Bn |
| Dec 31, 2020 | 3.62 Bn |
| Sep 30, 2020 | 3.45 Bn |
| Jun 30, 2020 | 3.39 Bn |
| Mar 31, 2020 | 3.45 Bn |
| Dec 31, 2019 | 3.30 Bn |
| Sep 30, 2019 | 3.35 Bn |
| Jun 30, 2019 | 3.29 Bn |
| Mar 31, 2019 | 3.21 Bn |
| Dec 31, 2018 | 3.11 Bn |
| Sep 30, 2018 | 3.18 Bn |
| Jun 30, 2018 | 3.19 Bn |
| Mar 31, 2018 | 3.25 Bn |
| Dec 31, 2017 | 3.21 Bn |
| Sep 30, 2017 | 2.42 Bn |
| Jun 30, 2017 | 2.10 Bn |
| Mar 31, 2017 | 2.05 Bn |
| Dec 31, 2016 | 1.81 Bn |
| Sep 30, 2016 | 1.83 Bn |
| Jun 30, 2016 | 1.81 Bn |
| Mar 31, 2016 | 1.83 Bn |
| Dec 31, 2015 | 1.77 Bn |
| Sep 30, 2015 | 1.83 Bn |
| Jun 30, 2015 | 1.64 Bn |
| Mar 31, 2015 | 1.55 Bn |
| Dec 31, 2014 | 1.59 Bn |
| Sep 30, 2014 | 1.55 Bn |
| Jun 30, 2014 | 1.56 Bn |
| Mar 31, 2014 | 1.56 Bn |
| Dec 31, 2013 | 1.19 Bn |
| Sep 30, 2013 | 1.18 Bn |
| Jun 30, 2013 | 1.19 Bn |
| Mar 31, 2013 | 1.16 Bn |
| Dec 31, 2012 | 1.16 Bn |
| Sep 30, 2012 | 1.19 Bn |
| Jun 30, 2012 | 1.16 Bn |
| Mar 31, 2012 | 1.16 Bn |
| Dec 31, 2011 | 1.14 Bn |
| Sep 30, 2011 | 1.17 Bn |
| Jun 30, 2011 | 1.15 Bn |
| Mar 31, 2011 | 1.01 Bn |
| Dec 31, 2010 | 1.02 Bn |
| Sep 30, 2010 | 959.28 Mn |
| Jun 30, 2010 | 941.80 Mn |
| Dec 31, 2009 | 940.10 Mn |